On June 21, 2023, Nicholas Haft resigned from the Board of Directors of Finch Therapeutics Group, Inc., effective as of June 23, 2023. Mr. Haftâs decision to resign as a member of the Board was not the result of any disagreement between Mr. Haft and the Company on any matters relating to the Companyâs operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +3.57% | +3.57% | -35.73% |
Mar. 25 | Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 12 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-35.73% | 3.73M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- FNCH Stock
- News Finch Therapeutics Group, Inc.
- Finch Therapeutics Group, Inc. Announces Resignation of Nicholas Haft as Member of Board